Literature DB >> 24986014

The evolving practice of hybrid natural orifice transluminal endoscopic surgery (NOTES) for rectal cancer.

Chien-Chih Chen1, Yi-Ling Lai, Jeng-Kae Jiang, Chun-Ho Chu, I-Ping Huang, Wei-Shone Chen, Andy Yi-Ming Cheng, Shung-Haur Yang.   

Abstract

BACKGROUND: Natural orifice transluminal endoscopic surgery (NOTES) has emerged as the area of focus in laparoscopic surgery. Hybrid NOTES (hNOTES) has some potential advantages for treating rectal cancer.
METHODS: Between May 2013 and November 2013, a total of 20 patients (11 males) who received hNOTES at two institutes participating in the study were documented and reviewed. Surgical outcomes, including complications and pathological outcomes, were analyzed.
RESULTS: The mean age of patients was 57.8 ± 10.1 years (range 34-78). Eleven patients received preoperative neoadjuvant chemoradiotherapy, with the mean distance between tumor and anal verge being 5.9 ± 1.7 cm (mean 2-8). The mean estimated intraoperative blood loss was 68 ± 106 ml (range 30-500), with one case converted to open procedure due to uncontrolled bleeding. Eight cases underwent simultaneous two-team approach. The mean operative time was 200.8 ± 47.7 min (range 110-285). Circular stapling was performed for 14 cases (70 %) as the anastomosis, and protective stoma performed for 17 cases (85 %). The overall postoperative complication rate was 25 %. Two cases (10 %) develop pelvic abscess due to leakage, which were controlled by medical treatments. The distal and circumferential margins were all free of tumor cells, and the mean distal margin length was 2.4 ± 0.98 cm (range 0.5-4).
CONCLUSIONS: Hybrid NOTES for rectal cancer is safe and feasible. Rapid experience-building accelerates its evolution, as reflected here by the high stapling rate and the idea of a two-team approach. It has the potential to become an option of treating rectal cancers.

Entities:  

Mesh:

Year:  2014        PMID: 24986014     DOI: 10.1007/s00464-014-3659-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  16 in total

1.  Incidence of and risk factors for anastomotic leakage after laparoscopic anterior resection with intracorporeal rectal transection and double-stapling technique anastomosis for rectal cancer.

Authors:  Takashi Akiyoshi; Masashi Ueno; Yosuke Fukunaga; Satoshi Nagayama; Yoshiya Fujimoto; Tsuyoshi Konishi; Hiroya Kuroyanagi; Toshiharu Yamaguchi
Journal:  Am J Surg       Date:  2011-09       Impact factor: 2.565

2.  Minilaparoscopy-assisted transrectal low anterior resection (LAR): a preliminary study.

Authors:  Antonio M Lacy; Cedric Adelsdorfer; Salvadora Delgado; Patricia Sylla; David W Rattner
Journal:  Surg Endosc       Date:  2012-07-18       Impact factor: 4.584

3.  Is it appropriate to apply the enhanced recovery program to patients undergoing laparoscopic rectal surgery?

Authors:  Chien-Chih Chen; I-Ping Huang; Mei-Ching Liu; James Jer-Min Jian; Skye Hon-Chun Cheng
Journal:  Surg Endosc       Date:  2010-10-29       Impact factor: 4.584

4.  Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.

Authors:  Morten T Eriksen; Arne Wibe; Jon Haffner; Johan N Wiig
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

5.  Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer.

Authors:  H Zhang; Y-S Zhang; X-W Jin; M-Z Li; J-S Fan; Z-H Yang
Journal:  Tech Coloproctol       Date:  2012-08-31       Impact factor: 3.781

6.  NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance.

Authors:  Patricia Sylla; David W Rattner; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2010-02-26       Impact factor: 4.584

7.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.

Authors:  Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

8.  Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): a stepwise description of the surgical technique with video demonstration.

Authors:  S Atallah; M Albert; T DeBeche-Adams; G Nassif; H Polavarapu; S Larach
Journal:  Tech Coloproctol       Date:  2013-02-02       Impact factor: 3.781

9.  No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery.

Authors:  Joël Leroy; Brian Donncha Barry; Armando Melani; Didier Mutter; Jacques Marescaux
Journal:  JAMA Surg       Date:  2013-03       Impact factor: 14.766

10.  A pilot study of natural orifice transanal endoscopic total mesorectal excision with laparoscopic assistance for rectal cancer.

Authors:  Patricia Sylla; Liliana G Bordeianou; David Berger; Kyung S Han; Gregory Y Lauwers; Dushyant V Sahani; Mohammed A Sbeih; Antonio M Lacy; David W Rattner
Journal:  Surg Endosc       Date:  2013-04-10       Impact factor: 4.584

View more
  12 in total

1.  Transanal total mesorectal excision for rectal cancer: a preliminary report.

Authors:  Liang Kang; Wen-Hao Chen; Shuang-Ling Luo; Yan-Xin Luo; Zhi-Hua Liu; Mei-Jin Huang; Jian-Ping Wang
Journal:  Surg Endosc       Date:  2015-08-27       Impact factor: 4.584

Review 2.  Transanal total mesorectal excision for rectal cancer: hype or new hope?

Authors:  Chien-Chih Chen; Yi-Ling Lai; Andy Yi-Ming Cheng; Chun-Ho Chu; I-Ping Huang; Shung-Haur Yang
Journal:  J Gastrointest Oncol       Date:  2019-12

3.  Trans-anal surgery with the taTME technique for rectal gastrointestinal stromal tumors: a retrospective study.

Authors:  Takahiro Shigaki; Yuichiro Tsukada; Koichi Teramura; Hiro Hasegawa; Koji Ikeda; Yuji Nishizawa; Takeshi Sasaki; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2022-08-09       Impact factor: 2.796

4.  Transanal total mesorectal excision assisted by single-port laparoscopic surgery for low rectal cancer.

Authors:  W-H Chen; L Kang; S-L Luo; X-W Zhang; Y Huang; Z-H Liu; J-P Wang
Journal:  Tech Coloproctol       Date:  2015-07-29       Impact factor: 3.781

Review 5.  Transanal total mesorectal excision: Towards standardization of technique.

Authors:  Albert M Wolthuis; Gabriele Bislenghi; Anthony de Buck van Overstraeten; André D'Hoore
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 6.  Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature.

Authors:  Nicola de'Angelis; Luca Portigliotti; Daniel Azoulay; Francesco Brunetti
Journal:  Langenbecks Arch Surg       Date:  2015-10-26       Impact factor: 3.445

Review 7.  Total mesorectal excision laparoscopic versus transanal approach for rectal cancer: A systematic review and meta-analysis.

Authors:  Salvatore Lo Bianco; Katia Lanzafame; Caterina Domenica Piazza; Vincenzo Gaetano Piazza; Daniele Provenzano; Diego Piazza
Journal:  Ann Med Surg (Lond)       Date:  2022-01-24

8.  Natural orifice transluminal endoscopic surgery for colorectal cancer.

Authors:  P N Hiep; H H Thien; P A Vu; P H Thanh; N T Xuan
Journal:  BJS Open       Date:  2017-05-24

9.  Glove single-port laparoscopy-assisted transanal total mesorectal excision for low rectal cancer: a preliminary report.

Authors:  Wanglin Li; Boye Dong; Baifu Peng; Jiabao Lu; Zixin Wu; Guanwei Li; Jie Cao
Journal:  World J Surg Oncol       Date:  2019-11-30       Impact factor: 2.754

10.  Neoadjuvant concurrent chemoradiotherapy followed by transanal total mesorectal excision assisted by single-port laparoscopic surgery for low-lying rectal adenocarcinoma: a single center study.

Authors:  Yen-Jung Lu; Chien-Hsin Chen; En-Kwang Lin; Szu-Yuan Wu
Journal:  World J Surg Oncol       Date:  2020-08-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.